Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases. | ![]() Sagent Pharmaceuticals Sagent Pharmaceuticals is focused on developing, manufacturing, sourcing and marketing pharmaceutical products. | Spirovant Sciences Spirovant Sciences is a company focused on the development of gene therapies for treating and curing cystic fibrosis and other lung diseases. | |
Founding Date | Founding Date 1878 | Founding Date 2006 | Founding Date 2016 |
Type | Type Public | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more | Locations Schaumburg, US HQ | Locations Philadelphia, US HQ |
Employees | Employees 4,955 | Employees 2261% increase | Employees 234% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) ¥499.7b (FY, 2026) | Revenue (est.) $318.3m (FY, 2015) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥55.5b (FY, 2026) | Cost of goods $230.6m (FY, 2015) | Cost of goods N/A |
Gross profit | Gross profit ¥491.3b (FY, 2026) | Gross profit $87.7m (FY, 2015) | Gross profit N/A |
Net income | Net income ¥205.9b (FY, 2026) | Net income ($21.9m) (FY, 2015) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 4.7m | Total funding raised $ 70m | Total funding raised N/A |

Sagent Pharmaceuticals is focused on developing, manufacturing, sourcing and marketing pharmaceutical products.
View companySpirovant Sciences is a company focused on the development of gene therapies for treating and curing cystic fibrosis and other lung diseases.
View company